Concepedia

Rena Harrigan

RH

Statistics

Publications

3

Citations

234

H-Index

3

Active since

2006

Affiliations

Halozyme Therapeutics (United States)(Current)

Rena Harrigan is an author at Halozyme Therapeutics (United States) specializing in translational medicine, dermatology, and molecular pharmacology.

Top concepts

Publications per year

2006–2020

3

Publications

3

Safety and tolerability of concurrent natalizumab treatment for patients with Crohnʼs disease not in remission while receiving infliximab

Bruce E. Sands, Richard A. Kozarek, Jack B. Spainhour et al. · Inflammatory Bowel Diseases · 2006 · 195 citations

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers

Marie A. Printz, Samuel S. Dychter, Emanuel DeNoia et al. · Current Therapeutic Research · 2020 · 20 citations · Full text

Tolerability and Pharmacokinetic Properties of Ondansetron Administered Subcutaneously With Recombinant Human Hyaluronidase in Minipigs and Healthy Volunteers

Samuel S. Dychter, Rena Harrigan, Jesse Bahn et al. · Clinical Therapeutics · 2014 · 19 citations

, , +5

1–3 of 3